ENVELO Trademark

Trademark Overview

On Tuesday, June 1, 2021, a trademark application was filed for ENVELO with the United States Patent and Trademark Office. The USPTO has given the ENVELO trademark a serial number of 90747312. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, September 30, 2025. This trademark is owned by Tulavi Therapeutics, Inc.. The ENVELO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, hydrogel for medical purposes
envelo

General Information

Serial Number90747312
Word MarkENVELO
Filing DateTuesday, June 1, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, September 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Goods and ServicesPharmaceuticals, namely, hydrogel for medical purposes
Translation of Words in MarkThe wording ENVELO has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTulavi Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Gatos, CA 95032
Party NameTulavi Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Friday, June 4, 2021NEW APPLICATION ENTERED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2022ASSIGNED TO EXAMINER
Thursday, February 17, 2022NON-FINAL ACTION WRITTEN
Thursday, February 17, 2022NON-FINAL ACTION E-MAILED
Thursday, February 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2023SOU EXTENSION 2 FILED
Wednesday, November 22, 2023SOU EXTENSION 2 GRANTED
Friday, November 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2023SOU EXTENSION 1 FILED
Tuesday, May 9, 2023SOU EXTENSION 1 GRANTED
Thursday, May 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 3 FILED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 2, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2024SOU EXTENSION 4 FILED
Tuesday, May 13, 2025SOU EXTENSION 5 FILED
Tuesday, September 30, 2025SOU EXTENSION 5 GRANTED
Tuesday, September 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 1, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 14, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2024SOU EXTENSION 4 GRANTED

Related Keywords

envelo purposes medical hydrogel namely pharmaceuticals